Search research articles
Contact Us
Filters
Showing results (381-390 of 419) with videos related to
Page
of 42
Sort By:
Neurology
|
July 1, 1993
The natural history of amyotrophic lateral sclerosis
S P Ringel, J R Murphy, M K Alderson, et al.
Computer Methods and Programs in Biomedicine
|
April 15, 2000
DEMS - a second generation diabetes electronic management system
C A Gorman, B R Zimmerman, S A Smith, et al.
American Journal of Human Genetics
|
January 1, 1995
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium
S A Narod, D Ford, P Devilee, et al.
The Journal of Biological Chemistry
|
September 15, 2001
The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages
H Vosper, L Patel, T L Graham, et al.
The Journal of Clinical Investigation
|
January 31, 1998
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
M Adams, C T Montague, J B Prins, et al.
The Journal of Family Practice
|
December 1, 1995
Subgaleal hematoma: the need for increased awareness of risk
S A Smith, P L Jett, S L Jacobson, et al.
Cytogenetics and Cell Genetics
|
January 1, 1994
Cytogenetic nomenclature of deer mice, Peromyscus (Rodentia): revision and review of the standardized karyotype. Report of the Committee for the Standardization of Chromosomes of Peromyscus
I F Greenbaum, S J Gunn, S A Smith, et al.
Clinical and Translational Radiation Oncology
|
August 4, 2018
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours
M T Dillon, Z Boylan, D Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2021
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy
R Kim, M Kwon, M An, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2021
Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women
Y Yue, J Hur, Y Cao, et al.
Page
of 42
Search research articles
Search
Showing results (381-390 of 419) with videos related to
Sort By:
Page
of 42
Neurology
|
July 1, 1993
The natural history of amyotrophic lateral sclerosis
S P Ringel, J R Murphy, M K Alderson, et al.
Computer Methods and Programs in Biomedicine
|
April 15, 2000
DEMS - a second generation diabetes electronic management system
C A Gorman, B R Zimmerman, S A Smith, et al.
American Journal of Human Genetics
|
January 1, 1995
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium
S A Narod, D Ford, P Devilee, et al.
The Journal of Biological Chemistry
|
September 15, 2001
The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages
H Vosper, L Patel, T L Graham, et al.
The Journal of Clinical Investigation
|
January 31, 1998
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
M Adams, C T Montague, J B Prins, et al.
The Journal of Family Practice
|
December 1, 1995
Subgaleal hematoma: the need for increased awareness of risk
S A Smith, P L Jett, S L Jacobson, et al.
Cytogenetics and Cell Genetics
|
January 1, 1994
Cytogenetic nomenclature of deer mice, Peromyscus (Rodentia): revision and review of the standardized karyotype. Report of the Committee for the Standardization of Chromosomes of Peromyscus
I F Greenbaum, S J Gunn, S A Smith, et al.
Clinical and Translational Radiation Oncology
|
August 4, 2018
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours
M T Dillon, Z Boylan, D Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2021
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy
R Kim, M Kwon, M An, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2021
Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women
Y Yue, J Hur, Y Cao, et al.
Page
of 42